Theodrenaline: Difference between revisions
m Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +) |
No edit summary |
||
| Line 24: | Line 24: | ||
| routes_of_administration = | | routes_of_administration = | ||
}} | }} | ||
__NOTOC__ | |||
{{SI}} | |||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
'''Theodrenaline''' (or '''noradrenaline theophylline''') is a cardiac stimulant. | '''Theodrenaline''' (or '''noradrenaline theophylline''') is a cardiac stimulant. It is sometimes combined with [[cafedrine]].<ref name="pmid16633089">{{cite journal |author=Usichenko TI |title=Akrinor-induced relaxation of pig coronary artery in vitro is transformed into alpha1-adrenoreceptor-mediated contraction by pretreatment with propranolol |journal=J. Cardiovasc. Pharmacol. |volume=47 |issue=3 |pages=450–5 |date=March 2006 |pmid=16633089 |doi=10.1097/01.fjc.0000211710.87863.89 |url=http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00005344-200603000-00017 |author-separator=, |author2=Foellner S |author3=Gruendling M |display-authors=3 |last4=Feyerherd |first4=F |last5=Lehmann |first5=C |last6=Wendt |first6=M |last7=Pavlovic |first7=D}}</ref> | ||
==References== | |||
{{reflist|2}} | |||
{{Cardiac stimulants excluding cardiac glycosides}} | {{Cardiac stimulants excluding cardiac glycosides}} | ||
[[Category:Catecholamines]] | |||
[[Category:Xanthines]] | [[Category:Xanthines]] | ||
[[Category:Drugs]] | [[Category:Cardiovascular Drugs]] | ||
[[Category:Drug]] | |||
Revision as of 00:42, 24 July 2014
 | |
| Clinical data | |
|---|---|
| ATC code | |
| Identifiers | |
| |
| PubChem CID | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C17H21N5O5 |
| Molar mass | 375.379 g/mol |
|
WikiDoc Resources for Theodrenaline |
|
Articles |
|---|
|
Most recent articles on Theodrenaline Most cited articles on Theodrenaline |
|
Media |
|
Powerpoint slides on Theodrenaline |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Theodrenaline at Clinical Trials.gov Trial results on Theodrenaline Clinical Trials on Theodrenaline at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Theodrenaline NICE Guidance on Theodrenaline
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Theodrenaline Discussion groups on Theodrenaline Patient Handouts on Theodrenaline Directions to Hospitals Treating Theodrenaline Risk calculators and risk factors for Theodrenaline
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Theodrenaline |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Theodrenaline (or noradrenaline theophylline) is a cardiac stimulant. It is sometimes combined with cafedrine.[1]
References
- ↑ Usichenko TI; Foellner S; Gruendling M; et al. (March 2006). "Akrinor-induced relaxation of pig coronary artery in vitro is transformed into alpha1-adrenoreceptor-mediated contraction by pretreatment with propranolol". J. Cardiovasc. Pharmacol. 47 (3): 450–5. doi:10.1097/01.fjc.0000211710.87863.89. PMID 16633089. Unknown parameter
|author-separator=ignored (help)
- Pages with script errors
- Pages with citations using unsupported parameters
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Catecholamines
- Xanthines
- Cardiovascular Drugs
- Drug